By expenditures
| Name | Title | Type |
|---|---|---|
| Mallory Eickhoff | Director | Auditee |
| Damien Curry | Chief Financial Officer | Auditee |
| Roselle Bonnoitt | Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 409917 | 2025 | 2026-08-27 | CHERRY BEKAERT LLP | $13.75M |
| 366380 | 2024 | 2025-09-16 | Cherry Bekaert LLP | $15.12M |
| 336187 | 2023 | 2025-01-07 | Cherry Bekaert LLP | $10.25M |
| 10130 | 2022 | 2024-01-08 | Cherry Bekaert LLP | $12.92M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 409917 | 2025 | 2026-08-27 | 1228098 | 2025-003 | Material Weakness | Yes | N |
| 409917 | 2025 | 2026-08-27 | 1228097 | 2025-003 | Material Weakness | Yes | N |
| 409917 | 2025 | 2026-08-27 | 1228096 | 2025-003 | Material Weakness | Yes | N |
| 409917 | 2025 | 2026-08-27 | 1228095 | 2025-003 | Material Weakness | Yes | N |
| 409917 | 2025 | 2026-08-27 | 1228094 | 2025-002 | Material Weakness | Yes | N |
| 409917 | 2025 | 2026-08-27 | 1228093 | 2025-002 | Material Weakness | Yes | N |
| 409917 | 2025 | 2026-08-27 | 1228092 | 2025-002 | Material Weakness | Yes | N |
| 409917 | 2025 | 2026-08-27 | 1228091 | 2025-002 | Material Weakness | Yes | N |
| 366380 | 2024 | 2025-09-16 | 1153151 | 2024-002 | Material Weakness | Yes | N |
| 366380 | 2024 | 2025-09-16 | 1153150 | 2024-002 | Material Weakness | Yes | N |
| 366380 | 2024 | 2025-09-16 | 1153149 | 2024-002 | Material Weakness | Yes | N |
| 366380 | 2024 | 2025-09-16 | 1153148 | 2024-002 | Material Weakness | Yes | N |
| 366380 | 2024 | 2025-09-16 | 1153147 | 2024-003 | Material Weakness | Yes | N |
| 366380 | 2024 | 2025-09-16 | 1153146 | 2024-003 | Material Weakness | Yes | N |
| 366380 | 2024 | 2025-09-16 | 1153145 | 2024-003 | Material Weakness | Yes | N |
| 366380 | 2024 | 2025-09-16 | 1153144 | 2024-003 | Material Weakness | Yes | N |
| 10130 | 2022 | 2024-01-08 | 584243 | 2022-003 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 584242 | 2022-002 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 584241 | 2022-001 | Significant Deficiency | Yes | E |
| 10130 | 2022 | 2024-01-08 | 584240 | 2022-003 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 584239 | 2022-002 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 584238 | 2022-001 | Significant Deficiency | Yes | E |
| 10130 | 2022 | 2024-01-08 | 584237 | 2022-003 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 584236 | 2022-002 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 584235 | 2022-001 | Significant Deficiency | Yes | E |
| 10130 | 2022 | 2024-01-08 | 584234 | 2022-003 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 584233 | 2022-002 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 584232 | 2022-001 | Significant Deficiency | Yes | E |
| 10130 | 2022 | 2024-01-08 | 7801 | 2022-003 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 7800 | 2022-002 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 7799 | 2022-001 | Significant Deficiency | Yes | E |
| 10130 | 2022 | 2024-01-08 | 7798 | 2022-003 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 7797 | 2022-002 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 7796 | 2022-001 | Significant Deficiency | Yes | E |
| 10130 | 2022 | 2024-01-08 | 7795 | 2022-003 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 7794 | 2022-002 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 7793 | 2022-001 | Significant Deficiency | Yes | E |
| 10130 | 2022 | 2024-01-08 | 7792 | 2022-003 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 7791 | 2022-002 | Significant Deficiency | Yes | N |
| 10130 | 2022 | 2024-01-08 | 7790 | 2022-001 | Significant Deficiency | Yes | E |